Premium
Topical carmustine (BCNU) in the treatment of mycosis fungoides
Author(s) -
Zackheim Herschel S.
Publication year - 2003
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/j.1396-0296.2003.01641.x
Subject(s) - carmustine , mycosis fungoides , medicine , dermatology , mycosis , chemotherapy , surgery , lymphoma , etoposide
The University of California, San Francisco (UCSF), experience with topical carmustine (BCNU) in the treatment of approximately 200 patients with mycosis fungoides (MF) is summarized. Topical BCNU is an effective treatment for patch‐ and early plaque‐stage MF. Side‐effects are usually not a major deterrent to continuation of therapy.